Literature DB >> 2521284

Effects of calcium antagonists and nitroglycerin on atrial natriuretic peptide in normal subjects and patients with essential hypertension.

T Iwasaki1, A Niwa, T Shinoda, M Ishihara, T Aizawa, T Yamada.   

Abstract

Acute effects of coronary vasodilators (nifedipine, nicardipine, and nitroglycerin) on atrial natriuretic peptide (ANP) and the renin-angiotensin-aldosterone system were studied in normal subjects and patients with essential hypertension. Nifedipine lowered blood pressure both in normal subjects and in patients and elevated ANP, plasma renin activity, and angiotensin II in normal subjects but not in hypertensive patients. Nicardipine lowered blood pressure but failed to elevate ANP and angiotensin II in normal subjects. Nitroglycerin failed to elevate ANP in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521284     DOI: 10.1177/000331978904000105

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  4 in total

1.  Plasma atrial natriuretic peptide levels in essential hypertension after treatment with verapamil.

Authors:  B Kokkas; P Kotridis; M Karamouzis; I Kanonidis; G Sakadamis; G Dadous; S Haritos; P Kyriakoui; P C Papadopoulos; V Mirtsou-Fidani; C L Papadopoulos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jan-Mar       Impact factor: 2.441

2.  Effects of felodipine on atrial natriuretic peptide in hypertensive non-insulin dependent diabetes mellitus.

Authors:  R F Jeffrey; S Capewell; J Brown; A Collier; C Hajducka; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

Review 3.  Atrial natriuretic peptide contributes to the antihypertensive action of many drugs.

Authors:  C L Papadopoulos; B A Kokkas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Jan-Mar       Impact factor: 2.441

4.  Plasma atrial natriuretic peptide in essential hypertension after treatment with terazocin.

Authors:  P Kotridis; B Kokkas; P Kyriakou; M Karamouzis; G Salpigidis; C Karantona; J Karadoumanis; T Ginis; O Goulis; P C Papadopoulos; C Vakalopoulos; G Sakantamis; A Dimitriadou; V Mirtsou-Fidani; C L Papadopoulos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Apr-Jun       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.